Sunday, December 28, 2025

Penile Carcinoma: Epidemiology, Risk Factors, Pathology, Symptoms, Spread, Staging, Diagnosis, Treatment and Prevention

Penile Carcinoma

~Introduction


Penile carcinoma is a rare but aggressive malignant tumor arising from the tissues of the penis. It accounts for less than 1% of cancers in men in developed countries but has a higher incidence in developing nations, including parts of Asia, Africa, and South America. Despite its rarity, penile carcinoma carries significant morbidity and mortality due to delayed diagnosis, social stigma, and lack of awareness. Early detection and proper management are crucial for improving survival and preserving quality of life.

Most cases of penile carcinoma originate from the squamous epithelium, making squamous cell carcinoma (SCC) the most common histological type. The disease predominantly affects older men, usually between 50 and 70 years of age, although it can occasionally occur in younger individuals.

~Epidemiology

  • Incidence varies geographically

  • Rare in Western countries (0.1–1 per 100,000 men)

  • Higher incidence in India, Brazil, Africa, and Southeast Asia

  • More common in uncircumcised men

  • Higher prevalence in low socioeconomic groups

~Risk Factors

Several risk factors contribute to the development of penile carcinoma:

1. Lack of Circumcision

Uncircumcised men have a significantly higher risk due to accumulation of smegma, chronic inflammation, and poor hygiene.

2. Poor Genital Hygiene

Chronic irritation and inflammation of the penile epithelium predispose to malignant transformation.

3. Human Papillomavirus (HPV) Infection

  • HPV types 16 and 18 are strongly associated

  • Present in approximately 30–50% of penile cancers

  • Oncogenic HPV leads to cellular dysplasia and malignancy

4. Phimosis

Inability to retract the foreskin results in poor hygiene and chronic inflammation.

5. Smoking

Tobacco carcinogens cause DNA damage and increase cancer risk.

6. Chronic Inflammatory Conditions

  • Lichen sclerosus (balanitis xerotica obliterans)

  • Chronic balanitis

7. Multiple Sexual Partners

Increases risk of HPV infection.

~Precancerous Lesions of Penis

Certain premalignant conditions can progress to invasive carcinoma:

  1. Penile Intraepithelial Neoplasia (PeIN)

    • Carcinoma in situ

  2. Bowen’s Disease

    • On shaft of penis

  3. Erythroplasia of Queyrat

    • On glans penis

  4. Leukoplakia

    • White plaques with malignant potential

  5. Giant Condyloma (Buschke–Lowenstein tumor)

~Pathology

Gross Appearance

Penile carcinoma may present as:

  • Ulcerative lesion

  • Exophytic (cauliflower-like) growth

  • Indurated plaque or nodule

  • Foul-smelling discharge

  • Bleeding on touch

Common sites of involvement:

  • Glans penis (most common)

  • Prepuce

  • Coronal sulcus

  • Shaft (rare)

Histological Types

1. Squamous Cell Carcinoma (95%)

Subtypes include:

  • Usual type

  • Verrucous carcinoma (low-grade, slow growing)

  • Basaloid carcinoma (aggressive)

  • Warty carcinoma

  • Sarcomatoid carcinoma

2. Rare Types

  • Adenocarcinoma

  • Melanoma

  • Basal cell carcinoma

  • Lymphoma

  • Sarcoma

Microscopic Features (SCC)

  • Dysplastic squamous epithelium

  • Keratin pearl formation

  • Increased mitotic activity

  • Invasion into underlying stroma

  • Lymphovascular invasion in advanced disease

~Clinical Features

Early Symptoms

  • Painless lump or ulcer on penis

  • Red or white lesion on glans

  • Mild discharge

  • Local irritation or itching

Advanced Symptoms

  • Pain

  • Bleeding

  • Foul-smelling discharge

  • Difficulty in urination

  • Inguinal lymph node enlargement

  • Weight loss and fatigue in metastatic disease

~Spread of Penile Carcinoma

1. Local Spread

  • Invasion into corpora cavernosa and corpus spongiosum

2. Lymphatic Spread

  • Superficial inguinal lymph nodes (first)

  • Deep inguinal nodes

  • Pelvic lymph nodes

3. Hematogenous Spread

  • Rare

  • Lungs, liver, bones in advanced stages

~Staging (TNM Classification)

T – Primary Tumor

  • Tis: Carcinoma in situ

  • T1: Tumor invades subepithelial connective tissue

  • T2: Invades corpus spongiosum or cavernosum

  • T3: Invades urethra or prostate

  • T4: Invades adjacent structures

N – Lymph Nodes

  • N0: No nodal metastasis

  • N1–N3: Increasing lymph node involvement

M – Distant Metastasis

  • M0: No metastasis

  • M1: Distant metastasis present

~Diagnosis

1. Clinical Examination

  • Inspection and palpation of penile lesion

  • Assessment of inguinal lymph nodes

2. Biopsy (Gold Standard)

  • Incisional or punch biopsy

  • Confirms histological diagnosis

3. Imaging

  • Ultrasound for local extent

  • MRI for penile tissue invasion

  • CT scan for lymph node and distant spread

  • PET-CT in advanced cases

4. HPV Testing

  • Helpful for prognostic and research purposes

~Differential Diagnosis

  • Benign penile ulcer

  • Syphilitic chancre

  • Genital herpes

  • Condyloma acuminata

  • Peyronie’s disease

~Treatment

Management depends on stage, tumor size, lymph node involvement, and patient preference.

1. Treatment of Early-Stage Disease

Conservative Treatments

  • Topical chemotherapy (5-Fluorouracil)

  • Imiquimod cream

  • Laser ablation

  • Cryotherapy

  • Mohs micrographic surgery

Organ-Preserving Surgery

  • Wide local excision

  • Partial glansectomy

2. Treatment of Invasive Disease

Surgical Management

  • Partial penectomy

  • Total penectomy (advanced cases)

  • Perineal urethrostomy after total penectomy

Lymph Node Management

  • Sentinel lymph node biopsy

  • Inguinal lymph node dissection

3. Radiotherapy

  • External beam radiotherapy

  • Brachytherapy

  • Useful in early disease or patients unfit for surgery

4. Chemotherapy

Used in advanced or metastatic disease:

  • Cisplatin-based regimens

  • Combination chemotherapy (TIP: paclitaxel, ifosfamide, cisplatin)

5. Targeted and Immunotherapy

  • Emerging role

  • HPV-related tumors show better response

~Prognosis

Prognosis depends mainly on:

  • Tumor stage

  • Lymph node involvement

  • Histological grade

Survival Rates

  • Localized disease: 70–90%

  • Regional lymph node involvement: 30–50%

  • Distant metastasis: Poor prognosis

Early diagnosis significantly improves survival and penile preservation.

~Prevention

Primary Prevention

  • Neonatal circumcision

  • Proper genital hygiene

  • Safe sexual practices

  • HPV vaccination (effective against oncogenic strains)

Secondary Prevention

  • Early detection of precancerous lesions

  • Regular medical examination

  • Prompt biopsy of suspicious lesions

~Psychosocial Impact

Penile carcinoma causes:

  • Psychological distress

  • Sexual dysfunction

  • Body image issues

  • Social stigma

Multidisciplinary care including psychological support and counseling is essential.

~Conclusion

Penile carcinoma is a rare but potentially fatal malignancy that predominantly affects older, uncircumcised men. Squamous cell carcinoma is the most common histological type, strongly associated with HPV infection, poor hygiene, and chronic inflammation. Early diagnosis through biopsy and appropriate staging is vital for effective management. Treatment ranges from conservative therapies in early stages to radical surgery and chemotherapy in advanced disease. Preventive strategies such as circumcision, hygiene, HPV vaccination, and public awareness play a crucial role in reducing disease burden. With early intervention and modern therapeutic approaches, survival rates and quality of life can be significantly improved.


No comments:

Post a Comment

Mantle Cell Lymphoma: Causes, Symptoms, Diagnosis, Treatment, and Outlook

Mantle Cell Lymphoma: Causes, Symptoms, Diagnosis, Treatment, and Outlook Mantle Cell Lymphoma (MCL) is a rare and aggressive subtype of no...